U.S. Office REITs Stock News

Recent analyst activity around Karooooo (KARO) has focused on a series of upward earnings estimate revisions and an improved ranking. This has prompted investors to reassess how the stock’s recent performance aligns with these expectations. See our latest analysis for Karooooo. Karooooo’s recent 3.8% 1 day share price return at US$47.27 and 5.8% year to date share price return sit against a very large 3 year total shareholder return of about 12x, suggesting investors are weighing earlier...

H2O America recently announced that executive Kristen Johnson will depart the company without cause, effective 3 July 2026, with severance provided under her employment agreement. Alongside this leadership change, H2O America has extended its 58-year dividend growth streak with a 4.8% quarterly increase and reaffirmed its 2026 earnings guidance. Next, we’ll examine how Johnson’s departure and the continued dividend growth track record may influence H2O America’s broader investment...

Setting the stage for Air Products and Chemicals stock Air Products and Chemicals (APD) has attracted attention after recent share moves, with the stock closing at $281.62. Investors are weighing this level against the company’s size, profitability, and multi regional revenue base. See our latest analysis for Air Products and Chemicals. Recent price action has been mixed, with the 1 day share price return of 1.26% set against a 30 day share price return down 4.66%. The 5 year total...

Earlier this month, UDR Inc. announced it will shift from quarterly to monthly dividend payments starting in July and expanded its share repurchase authorization by US$25.00 million as part of a broader capital return plan. These changes in how UDR returns cash to shareholders, alongside recent insider selling by its CEO, highlight evolving signals about management’s confidence and capital priorities. Next, we’ll examine how UDR’s move to monthly dividends could influence its existing...

Recent trading snapshot and context Protagonist Therapeutics (PTGX) has drawn investor attention after recent share price moves, with the stock last closing at US$109.78 and posting gains over the past week, month and past 3 months. See our latest analysis for Protagonist Therapeutics. Looking beyond the latest move, Protagonist Therapeutics has shown strong momentum, with a 25.92% year to date share price return and a 94.75% total shareholder return over the past year. If you are tracking...

Noble Corporation plc recently priced an upsized US$800 million offering of 6.250% Senior Notes due 2034, completed in the past, with plans to use the proceeds and cash on hand to redeem its higher-coupon 8.500% Senior Secured Second Lien Notes due 2030 and US$300 million of 8.000% Senior Notes due 2030. This refinancing move highlights Noble’s effort to lower interest costs and reshape its debt profile, potentially supporting future financial flexibility and cash flow. We’ll now examine how...

Progressive (PGR) has drawn fresh attention after its stock gained 2.03% to close at US$204.20, outperforming major indices as traders positioned ahead of an earnings report that is expected to show lower EPS but higher revenue. See our latest analysis for Progressive. At around US$203.11 today, the recent 2.03% daily gain sits against a year to date share price return that is down 4.25%. The three year total shareholder return of 70.99% and five year total shareholder return of 146.08% point...

Bolt, Pony.ai, and Stellantis recently launched an autonomous mobility pilot in Luxembourg to test Pony.ai’s seventh-generation robotaxi on Stellantis’ L4-Ready midsize vans using Bolt’s ride-hailing platform. The project highlights Luxembourg’s supportive regulatory framework as a proving ground for validating Pony.ai’s autonomous driving technology and readiness for future European deployment. Next, we will examine how this European pilot, especially testing seventh-generation autonomous...

We wouldn't blame Expedia Group, Inc. ( NASDAQ:EXPE ) shareholders if they were a little worried about the fact that...

Ooma, Inc.'s ( NYSE:OOMA ) earnings announcement last week was disappointing for investors, despite the decent profit...

Sea (NYSE:SE) is back in focus after reporting 38% year over year revenue growth while simultaneously reinvesting in fulfillment, instant delivery, and other ecosystem services, and cutting several hundred Shopee developer roles globally. See our latest analysis for Sea. The latest quarter of 38% year over year revenue growth and reinvestment in Shopee and Monee is landing against a weaker share price backdrop. The stock is at US$82.94, the year to date share price return is down 36.92%, the...

Recent share performance and business snapshot Columbia Financial (CLBK) has drawn investor attention after a period of solid stock performance, with the share price at $20.70 and total return around 49% over the past year. For context, the bank holding company reports annual revenue of about $259.2 million and net income of $55.97 million, with both revenue and profit showing positive annual growth rates based on the latest figures provided. The stock’s gains of about 6% over the past month...

Investors may be considering whether W.W. Grainger at around US$1,315 per share still offers value, or if most of the opportunity is already priced in. The stock has posted returns of 1.2% over the last week, 3.4% over the last month, 31.1% year to date and 24.7% over the past year, which can change how investors think about both its potential and its risks. Recent coverage has focused on W.W. Grainger's role in industrial distribution and how it is positioning its operations and customer...

We wouldn't blame NRC Health ( NASDAQ:NRC ) shareholders if they were a little worried about the fact that Michael...

Earlier in June 2026, Alvotech reported that the FDA accepted its Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio for intravenous use, while also resubmitting BLAs for AVT05 and AVT06 after enhancing its Reykjavik manufacturing facility and addressing regulatory observations. These regulatory milestones highlight Alvotech’s expanding biosimilar pipeline in immunology and ophthalmology and indicate progress in strengthening its quality systems under...

With war in Iran disrupting oil supplies, energy prices jumping and inflation back at a three year high, the mood in markets has shifted fast. Higher U.S. Treasury yields and talk of fresh Federal Reserve rate hikes are putting pressure on richly priced growth stories, while investors pay closer attention to cash flow and balance sheet strength. Dividend growth stocks with solid financial footing can look appealing in this kind of backdrop, but not all are affected in the same way. This...

Fresh IPOs are back in the spotlight, with the record SpaceX listing, a 19.2% first day surge, talk of Middle East peace helping crude oil prices, and stronger consumer sentiment all hitting the market at once. At the same time, stubborn inflation and a Federal Reserve that looks set to hold rates steady keep a lid on the easy-money story. Against this mix, some newly listed stocks have started to stand out. This article highlights 3 recent IPOs from the IPO Momentum Stocks screener. These...

Kennedy-Wilson Holdings (KW) has attracted fresh attention after recent trading, with the stock last closing at $10.93. For investors, that price stands in the context of mixed recent returns and sizeable exposure to global real estate. See our latest analysis for Kennedy-Wilson Holdings. Recent trading has been relatively muted, with a 1 day share price return of 0.09% and a 30 day share price return of 0.91%. However, a 13.38% year to date share price return sits alongside a 1 year total...

Some The J. M. Smucker Company ( NYSE:SJM ) shareholders may be a little concerned to see that the Chief Legal Officer...

Some Gen Digital Inc. ( NASDAQ:GEN ) shareholders may be a little concerned to see that the Director, Ondrej Vlcek...

Why Clear Channel Outdoor Holdings is on investors’ radar today Clear Channel Outdoor Holdings (CCO) has drawn investor attention after recent trading reflected modest short term gains, prompting closer scrutiny of how its current valuation lines up with its fundamentals and risk profile. See our latest analysis for Clear Channel Outdoor Holdings. At a share price of $2.41, Clear Channel Outdoor Holdings has seen steady share price momentum, with a 13.68% year to date share price return and a...

Recent commentary on TransDigm Group highlights that its core aircraft components business has delivered strong organic revenue growth, expanding profitability, and robust free cash flow generation, underpinned by high-margin aftermarket sales of mission-critical parts. An interesting nuance is that this operational strength coexists with recent insider share sales, suggesting executives are realizing gains even as external assessments still score the company highly on profitability and...

Global trade is picking up again, with AI hardware, semiconductors, and advanced electronics right at the center of that shift. For investors, this news event is a cue to look closely at companies that sit along these supply chains, from chip manufacturers to component suppliers and equipment makers. Some stocks could benefit from stronger export trends, inventory rebuilding, and supply chain expansion across Asia, while others may face pressure from policy risks and competition. This article...

On June 2, 2026, Pebblebrook Hotel Trust amended its Maryland Declaration to allow shareholders to remove trustees without cause, following prior shareholder approval. This governance change, alongside recent insider share purchases amid revised 2026 net income guidance and a US$19.27 million Q1 net loss on US$345.66 million in revenue, has become a focal point for investors reassessing the REIT’s risk–reward profile. We’ll now examine how the expanded right to remove trustees without cause...